Rashieda Gluck
Technik-/Wissenschafts-/F&E-Leiter bei DIANTHUS THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Rashieda Gluck
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 29 | |
| Public Company | Biotechnology | 22 | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Qu Biologics, Inc.
 Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada.
1
| Holding Company | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rashieda Gluck
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member President Human Resources Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ACCELERON PHARMA INC. | Biotechnology | Corporate Officer/Principal Compliance Officer | |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Investor Relations Contact | |
| TESARO INC | Pharmaceuticals: Major | Founder Investor Relations Contact | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor Private Equity Investor | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin Doctorate Degree | |
| McGill University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| Temple University (Pennsylvania) | College/University | Director/Board Member Masters Business Admin | |
| University of British Columbia | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
| University of Calgary | College/University | Undergraduate Degree Undergraduate Degree | |
| MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| University of Basel | College/University | Doctorate Degree Graduate Degree | |
Innovate BC
 Innovate BC Miscellaneous Commercial ServicesCommercial Services Innovate BC develops entrepreneurial talent and supports commercializing technology. The firm focuses on competitively positioning British Columbia in today's global knowledge economy in order to provide significant employment opportunities and a high standard of living for British Columbians. The company was founded in 1978 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman Chairman | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The United Way of the Lower Mainland
 The United Way of the Lower Mainland Investment Trusts/Mutual FundsMiscellaneous The United Way of the Lower Mainland is a non-profit organization based in Burnaby, CA. The non-profit company provides planning guides and resources to help coordinate successful United Way BC campaigns. The organization serves over 4 million British Columbians with a focus on supporting kids & youth, seniors, poverty, mental health, and food security. The Canadian company's mission is to support healthy, caring, and inclusive communities by strengthening vital connections that support people in need. | Investment Trusts/Mutual Funds | President Corporate Officer/Principal | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
MGI PHARMA Biologics, Inc.
 MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact | |
| ATHERSYS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| TREVENA, INC. | Pharmaceuticals: Major | Chairman Founder | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
OM Pharma SA
 OM Pharma SA Pharmaceuticals: MajorHealth Technology OM Pharma SA engages in manufacture of pharmaceutical products. Its portfolio includes products for respiratory tract infections, lower urinary tract infections, chronic venous insufficiency, microangiopathies, hemorrhoids, and menometrorrhagia. The company was founded by Jean-Rene Ricard in 1937 and is headquartered in Meyrin, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Opterion Health AG
 Opterion Health AG Medical/Nursing ServicesHealth Services Opterion Health AG is a Swiss company that focuses on bringing innovation to dialysis care and fostering home dialysis to improve the quality of life for patients suffering from end-stage renal disease (ESRD). Opterion Health is based in Muttenz, CH. The private company aims to increase the survival rates of people with ESRD and reduce healthcare costs. The company was founded in 2012 by Guido Grentzmann, and the CEO is Bjorn Englund. | Medical/Nursing Services | Chairman Director/Board Member | |
Actimed Therapeutics Ltd.
 Actimed Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Actimed Therapeutics Ltd. is a British clinical stage specialty pharmaceutical company that focuses on bringing innovation to the treatment of muscle wasting disorders. Actimed is based in Ascot, UK. Actimed's lead product, ACM-001 (S-pindolol), targets multiple biological pathways that drive cachexia and has generated promising proof of concept data in a phase II clinical trial in patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The company is currently preparing for further clinical studies of cachexia in these two cancer types. The company was founded in 2017 by Stefan D. Anker and Andrew Justin Stewart Coats, two world-leading physicians in muscle wasting research, together with Yann Colardelle, a professional in communications and medical education. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Viridian LLC
 Viridian LLC BiotechnologyHealth Technology Viridian LLC operates as a biopharmaceutical incubator. It focuses in the discovery and development of new molecular entities. The company was founded by Peter Harwin and Tomas Kiselak in 2016 and is headquartered in Philadelphia, PA. | Biotechnology | Chief Executive Officer Founder |
Statistik
International
| Vereinigte Staaten | 30 |
| Kanada | 14 |
| Schweiz | 5 |
| Deutschland | 2 |
| Japan | 2 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Finance | 3 |
| Health Services | 3 |
Operativ
| Director/Board Member | 301 |
| Corporate Officer/Principal | 134 |
| Independent Dir/Board Member | 95 |
| Chairman | 52 |
| Undergraduate Degree | 46 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Timothy Walbert | 40 |
| Kurt von Emster | 34 |
| Lonnie Moulder | 31 |
| Peter Greenleaf | 31 |
| Michael Hayden | 27 |
| David Ebsworth | 26 |
| Richard Glickman | 26 |
| R. MacKay-Dunn | 26 |
| Charles Rowland | 25 |
| Anne McGeorge | 25 |
| George Milne | 24 |
| Alison Lawton | 24 |
| Benjamin Rovinski | 22 |
| Jill Leversage | 20 |
| Jeff Randall | 17 |
- Börse
- Insiders
- Rashieda Gluck
- Unternehmensverbindungen
